FREE TRIAL
LOGIN
LOGIN

HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY

TRADE AIM SHARES
SEARCH COMPANIES
HIKMA PHARMACEUTICALS PLC ORD S HIK.L · LSE
Live
GBP 16.16 ▼ 0.12 (0.74%)
Mkt Cap £3.35B
Volume 444,436
52W 1,187.00 – 1,865.00
🔔 Sign in to receive sentiment alerts for HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY.
YOUR ALERTS

Market Sentiment

Sentiment Grade
A+
↑ Improving (+25.7 pts vs 7-day avg)
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Positive Sentiment
8.3/10
Sentiment Index
Very NegativeNeutralVery Positive
78%
Avg Confidence
29 / 1
Positive / Negative articles
📰 Based on 59 articles from 15 sources Yahoo Finance ×14 DirectorsTalk Interviews ×12 Yahoo Finance UK ×9 Proactive Investors ×8 This Site ×2
📊 Moderate volatility — MEVI 24.7/100
🕐 Updated 1 hour ago
Today's context

Daily AI-generated context for this company — recent events, market backdrop, and supporting developments. Available to Pro Investor members.

📊
Full Analysis Available to Paid Members
Paid members get full access to detailed sentiment charts, article-level analysis, social media sentiment, confidence breakdowns, and historical trends and sentiment outlook on all companies on the site.
Sign in Register

Latest RNS & Market News

  • HIKMA PHARMACEUTICALS PLC – Directorate Change
    RNS Number : 4813P Hikma Pharmaceuticals Plc 06 August 2026   Hikma appoints Tobias Hestler as a Director   London, 6 August 2026 – Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK) (Hikma) announces the appointment of Tobias Hestler as an independent Non-Executive Director with effect from 7 August 2026. Tobias will also be appointed a…
LOGIN

Search For A Company

RISK WARNING